Related by context. All words. (Click for frequent words.) 65 alpha#beta# integrin 65 Panzem 64 Ataluren 64 tafamidis 63 tramiprosate 63 RhuDex 63 R#/MEM # 63 Mipomersen 63 oral prodrug 62 Onconase 62 RSD# 62 menadione 62 orally dosed 62 EVIZON TM 62 Androxal TM 62 enzyme inhibitor 62 Aurora Kinase 62 VA# [002] 62 MyVax 62 inhibit metastasis 62 plasmid encoding 61 ATL# [001] 61 Darapladib 61 Iloperidone 61 atacicept 61 Safinamide 61 KSP inhibitor 61 CDP# 61 sitaxsentan 61 SGS# 61 Glypromate 61 Simulect 61 Belerofon 61 GLP1 agonist 61 Vascugel 61 Degarelix 61 Cethromycin 61 Dasatinib 61 Posiphen 61 JAK inhibitor 61 Initiates Clinical 61 PDE4 inhibitor 61 Olaparib 61 5 HT4 61 #ME# 61 Ocrelizumab 60 skip exon 60 CCR9 antagonist 60 bevasiranib 60 rBChE 60 Panzem R 60 ThGRF 60 gamma secretase inhibitor 60 Teriflunomide 60 ganaxolone 60 Anidulafungin 60 TG# [003] 60 tipifarnib 60 Tasimelteon 60 Systemic Delivery 60 HDAC Inhibitor 60 vidofludimus 60 CCR1 60 HQK 60 Triolex 60 Phase III Clinical Trial 60 Meets Primary Endpoint 60 alagebrium 60 defensin mimetic antibiotic 60 CCX# 60 Pancreate 60 Bryostatin 60 ATL# [002] 60 Archexin 60 ATL/TV# 60 ANAVEX #-# [003] 60 alefacept 60 Corgentin 60 GLP toxicology studies 60 Teriparatide 60 Laquinimod 60 Varespladib 60 Phase 2b Trial 60 OHR/AVR# 60 Fingolimod 60 ataluren 60 urocortin 2 59 Personalized Immunotherapy 59 Spiegelmers 59 Factor VIIa 59 Oral Calcitonin 59 2A receptor agonist 59 immunomodulatory properties 59 Urokinase 59 dystrophin expression 59 preclinically 59 Silodosin 59 Aplidin 59 Desmoteplase 59 Amplimexon 59 pharmacological chaperone 59 Phase IIB 59 EGFR signaling 59 Sapacitabine 59 PF # [002] 59 MyoCell SDF 1 59 Anti VEGF 59 Spiegelmer ® 59 Guanilib 59 Receptor Agonist 59 HuMax CD# 59 Vidofludimus 59 Anti Tumor 59 Catena ® 59 PPARγ 59 PDE# inhibitors 59 Antiangiogenic 59 Ampakine 59 Fx #A 59 Candesartan 59 Febuxostat 59 mGluR2 NAM 59 beta 1a 59 Microplasmin 59 OvaRex R 59 Davanat 59 Lixivaptan 59 PRT# 59 #beta HSD1 59 PCK# 59 microglial activation 59 Elafin 59 AMD# [003] 59 otelixizumab 59 Aliskiren 59 miglustat 59 DGAT1 59 Diamyd r vaccine 59 anti angiogenic agent 59 Symadex 59 Atrasentan 59 inhibiting mTOR 59 Trofex 59 cannabinor 59 Xanafide 59 midstage clinical 59 Curaxin CBLC# 59 Phase III Pivotal 59 ZOLINZA 59 vascular disrupting agents 59 pharmacodynamic effects 58 GGF2 58 Pazopanib 58 Lodamin 58 Curaxin 58 EOquin R 58 PresbyLens ® 58 Rescula 58 Pimavanserin 58 mGlu2 3 58 Granulocyte Colony Stimulating Factor 58 Omapro 58 polysaccharide polymer 58 5 HT6 receptor 58 Enzastaurin 58 PSMA ADC 58 Protease Inhibitor 58 DXL# 58 IL# PE#QQR 58 investigational humanized monoclonal antibody 58 TOCOSOL Camptothecin 58 mertansine 58 Zenapax 58 antifibrotic 58 Cethrin R 58 Cardio Vascu Grow 58 ELND# 58 selective inhibition 58 EZN 58 Epidermal Growth Factor Receptor 58 davunetide intranasal AL 58 NITD# 58 IRX 2 58 dexanabinol 58 anti CD3 58 orBec 58 isradipine 58 Darusentan 58 mTOR inhibition 58 INCB# [001] 58 Bezielle 58 Vernakalant 58 vWF 58 IND submission 58 Traficet EN 58 Vertex hepatitis C 58 triphendiol 58 lucinactant 58 acetylcholinesterase 58 selective modulator 58 Tyrima 58 adenosine A2A 58 amyloid formation 58 rhIL 7 58 ENMD # 58 tumorigenicity 58 indibulin 58 Drug Candidate 58 potent suppressor 58 Lpathomab 58 PDE# 58 ACV1 58 Prodrug 58 Akt activation 58 HuMax TAC 58 Azathioprine 58 Maribavir 58 Ophena 58 Squalamine 58 Cand5 58 vivo validation 58 ReN# 58 TRO# 58 BAL# [002] 58 VAPRISOL 58 Vidaza azacitidine 58 ATIR 58 androgen receptor AR 58 RhuDex R 58 alpha 2A adrenergic 58 HIF 1a 58 Cogane 58 DNA hypermethylation 58 BH4 58 Novel Antibiotic 58 IAP inhibitor 58 levodopa induced dyskinesia 58 Androxal 58 oral antiviral 58 Azacitidine 58 MAGE A3 ASCI 58 riociguat 58 aurora kinase 58 IIa trial 58 Natalizumab 58 BioGard 58 Novolimus 58 DNA intercalator 58 KRN# 58 non porcine pancreatic 58 Bosutinib 58 erlotinib Tarceva 57 NIC5 57 malignant ascites 57 Phase 2b Clinical Trial 57 E2F Decoy 57 Angiocept 57 Trandolapril 57 teplizumab 57 methylnaltrexone 57 neurotrophic 57 SNS# T 57 IND Application 57 ImmunoVEX HSV2 57 OMP #R# 57 Successfully Completes Phase 57 MetAP2 57 Lysteda 57 Initiate Phase 57 KL4 Surfactant 57 neuroregenerative 57 Denufosol 57 Cethrin 57 PSN# [002] 57 PKC# 57 GRN# 57 Azedra 57 Indomethacin 57 CRMD# 57 PEG SN# 57 epithelial barrier 57 AEG# 57 Bevasiranib 57 Lung Cancer Drug 57 Mucosal 57 VEGF receptor 57 histamine dihydrochloride 57 Smurf1 57 rifalazil 57 XmAb# 57 Fulvestrant 57 peroxidation 57 Talabostat 57 FDA Approvable Letter 57 faropenem medoxomil 57 MyVax personalized immunotherapy 57 RhuDex ® 57 tasimelteon 57 glucokinase 57 PARP inhibitor 57 cyclophilin D 57 anti CD3 antibody 57 nucleotide analog 57 huC# DM4 57 reslizumab 57 Anavex #-# 57 generation antisense inhibitor 57 Panzem R NCD 57 Plicera 57 Aganocide 57 antiarrhythmic 57 pharmacokinetic PK study 57 EP #R 57 Hedgehog antagonist 57 PD LID 57 Pivotal Clinical Trial 57 protein tyrosine phosphatase 1B 57 Alu RNA 57 Capesaris 57 Preos 57 TBC# 57 AZILECT R 57 SUVN 57 Phase IIA 57 midstage trials 57 ZFP TF 57 Viprinex 57 HuMax CD4 57 Saforis 57 NV1FGF 57 LRAT 57 Solulin 57 AZILECT ® 57 Gleevec resistant 57 Bafetinib 57 CDK inhibitor 57 small molecule Hedgehog 57 Tarceva TM 57 TGF beta pathway 57 AKT inhibitor 57 fosbretabulin 57 phase IIa clinical 57 LPA1 57 TH# [003] 57 Neurodex 57 Antisense 57 lomitapide 57 plasma pharmacokinetics 57 Muraglitazar 57 tryptase 57 Preclinical studies suggest 57 Onrigin 57 glucagon receptor 57 prostanoid 57 Phase 2a Clinical Trial 57 prostaglandin synthesis 57 antisense inhibition 57 Anticancer Agent 57 Fodosine 57 huN# DM1 57 Advagraf 57 MEVACOR 57 Octreotide 57 Kinase Inhibitor 57 CTCE 57 OMP #M# 57 enzastaurin 57 cathepsin K inhibitor 57 K ras mutations 57 receptor blocker 57 vivo potency 57 ruxolitinib 57 Completes Patient Enrollment 57 eritoran 57 antiproliferative effects 57 Vicriviroc 57 AOD# [002] 57 Arimoclomol 57 Factor IX 57 prostate epithelial cells 57 toxic beta amyloid 57 Sym# 57 OXi# 57 Crizotinib 57 Cellcept 57 Recombinant Human 57 Bucindolol 57 telomerase activator 57 GPR# [002] 57 GLPG# 57 Enzyme Replacement Therapy 57 Luveniq 57 CRF receptors 57 Firazyr 57 Memryte 57 NPD1 57 anticancer agent 57 SUTENT ® 57 PEGPH# 57 non nucleoside 56 Prodarsan 56 topically administered 56 immune modulating 56 Tesamorelin 56 Aflibercept 56 Corlux 56 Transdermal Patch 56 anticancer compound 56 AQ4N 56 Huntexil 56 histone deacetylase inhibitor 56 transthyretin 56 contractile muscle 56 MAXY VII 56 histone deacetylase HDAC 56 brivaracetam 56 Myocet 56 baminercept 56 CCR5 antagonist 56 YONDELIS 56 IAP inhibitors 56 Pivotal Phase III 56 Aclidinium 56 alkaline phosphatase ALP 56 ADAMTS# 56 uPA 56 GRNCM1 56 intranasal formulation 56 therapeutic monoclonal antibody 56 Kahalalide F 56 thrombin receptor 56 GSK# [002] 56 receptor inhibitor 56 VEGF inhibitor 56 SNT-MC#/idebenone 56 carcinoembryonic antigen 56 Diamyd R 56 BNC# 56 Factor NGF 56 talabostat 56 Dapagliflozin 56 systemically administered 56 Cytochrome P# 56 2DG 56 Ixabepilone 56 ISTODAX 56 zoledronic acid Zometa 56 Phase III Clinical Trials 56 mGluR5 antagonist 56 liprotamase 56 plasma kallikrein 56 inosine 56 ALK inhibitor 56 Cannabinor 56 cannabinoid receptor 56 thalidomide Thalomid 56 ProSavin 56 rEV# 56 Activity Assay 56 Vitaxin 56 PEGylated 56 TransVax tm 56 choroidal vasculopathy 56 SPC# [001] 56 Technosphere Insulin 56 nNOS 56 nonclinical studies 56 ALK inhibitors 56 novel prodrug 56 SILENOR 56 immunosuppressive medication 56 Ramelteon 56 VALSTAR 56 LY# [003] 56 Factor Xa inhibitor 56 HDL Selective Delipidation 56 Initiates Clinical Trial 56 maribavir 56 BLA filing 56 DPX Survivac 56 Aviptadil 56 HepDirect prodrug 56 Epratuzumab 56 Pathway Inhibitor 56 PEGylated Fab fragment 56 AERx iDMS 56 nicotinamide 56 ALV# 56 Phase 2a Trial 56 novel therapeutic antibodies 56 gefitinib Iressa 56 Alferon N 56 investigational oral anticoagulant 56 rindopepimut 56 Investigational Compound 56 favorable pharmacokinetic profile 56 AGTR1 56 Urocidin 56 olmesartan 56 adult mesenchymal stem 56 E#F# 56 hedgehog pathway 56 optimal dosing regimens 56 Boceprevir 56 Kevetrin ™ 56 Sphingomab 56 CXCR4 receptor 56 targeted radiotherapeutic 56 QRxPharma 56 Clinical Trial Results 56 Nebivolol 56 DORIBAX 56 samalizumab 56 chemoresistant 56 OvaDx 56 Troxatyl 56 Glucagon Like Peptide 56 rhMBL 56 Zoraxel 56 JAK2 Inhibitor 56 mTOR inhibitor 56 epothilones 56 neurotrophic factor 56 tramiprosate Alzhemed TM 56 Cladribine 56 ImmuKnow R 56 Sanctura XR 56 Ganciclovir 56 anti secretory 56 HoFH 56 EOquin TM 56 Reports Preclinical Data 56 Kamada AAT 56 corticosteroid dexamethasone 56 receptor tyrosine kinase inhibitor 56 StemEx 56 Dacogen decitabine 56 Submits Response 56 antiangiogenic 56 Deforolimus 56 FK# 56 Valproic acid 56 sGC 56 CEQ# 56 novel peptide 56 MEK inhibitor 56 octreotide implant 56 Resten NG 56 tezampanel 56 Maxy G# 56 PROCHYMAL 56 sd rxRNA 56 Montelukast 56 BRIM2 56 Urocidin TM 56 Initiates Enrollment 56 Phase #b/#a trial 56 angiogenesis inhibitor 56 PI3K/Akt pathway inhibitor 56 Olmesartan 56 PEDF 56 orally bioavailable 56 Fabry Disease 56 Investigational Treatment 56 Genz # 56 Nicotine Vaccine 56 ß amyloid 56 LymphoStat B TM 56 LibiGel ® 56 BZL# 56 Fondaparinux 56 isavuconazole 56 Liposomal 56 Pulmonary Arterial Hypertension 56 Initiates Phase II 56 muraglitazar 56 REP# 56 XYOTAX TM 56 endogenous ligands 56 BIM #A# 56 oral salmon calcitonin 56 rhIGF-I/rhIGFBP-3 56 voclosporin 56 PLK1 SNALP 56 alteplase 56 Septin 9 56 Prolongs Survival 56 FUS1 56 biologic therapeutics 56 outlicensed 56 Zenpep 56 HUCB cells 56 Nuvion 56 SNT MC# 56 Civacir 56 JAK Inhibitor 56 solanezumab 56 II Clinical Trial 56 Reverse Cholesterol Transport 56 vorinostat 56 Dose Ranging Study 56 Preclinical Study 56 CIP TRAMADOL ER 56 Atu# 56 STAT3 signaling 56 Gleevec imatinib mesylate 56 Inhalation Solution 56 Removab 56 Inosine 56 PRX# 56 Parathyroid Hormone 56 Lubiprostone 56 Glufosfamide 56 DCCR 55 MYDICAR ® 55 zotarolimus 55 Ozarelix 55 novel oral anticoagulant 55 Trastuzumab DM1 55 Phase 1b Clinical Trial 55 Prestara 55 Trabectedin 55 Calcitonin 55 elacytarabine 55 bortezomib Velcade 55 Lenocta 55 LPLD 55 IMA# 55 immune modulatory 55 intracellular uptake 55 edifoligide 55 Zebinix R 55 proteasome inhibitor 55 FTIs 55 Tyrosine Kinase Inhibitor 55 SomatoKine 55 Romidepsin 55 ATPace TM 55 NN# [001] 55 Initiate Clinical Trial 55 insulin secreting cells 55 adrenergic regulation 55 Fibrin Sealant 55 CXB# 55 PEARL SC 55 Daclizumab 55 nitrosothiols 55 nicotinic alpha 7 55 Pfizer maraviroc 55 Gattex 55 JAK2 enzyme 55 JAK3 inhibitor 55 EOquin 55 Phase III Trial 55 Velcade bortezomib 55 cromolyn sodium 55 Santaris 55 RECOTHROM R 55 Unit Dose Budesonide 55 MGd 55 Deferiprone 55 cancer neuroendocrine tumor 55 Complete Response 55 cysteamine 55 neovascular 55 experimentally induced 55 bardoxolone 55 autophagic 55 ELACYT 55 Files Investigational 55 Pivotal Phase 55 Balaglitazone 55 OGG1 55 PNP inhibitor 55 ERK1 2 55 Novel Oral 55 Arikace 55 TLK# 55 FVIII 55 Nasulin 55 DEB# 55 tolerogenic 55 EphB2 55 Universal Flu Vaccine 55 C1 INH 55 GW# [003] 55 AMPAKINE CX# 55 MT#/MEDI-# 55 albiglutide 55 blood clotting protein 55 multi kinase inhibitor 55 Cathepsin K 55 Injectable Suspension 55 Phase Ib study 55 Octreolin 55 incyclinide 55 Liprotamase 55 LUCASSIN 55 HepDirect technology 55 NDA Submission 55 CDDO Im 55 MEK inhibitor RDEA# 55 antitumor effect 55 Mycograb 55 TNFa 55 oxypurinol 55 Pegloticase 55 Myolimus 55 dose dependently 55 Human cl 55 Genasense ® oblimersen 55 tiapamil 55 RLY# 55 Relivar 55 GHRH 55 tremelimumab 55 LEUKINE 55 targeting CD# 55 small molecule activators 55 beta amyloid proteins 55 Six3 55 Vimpat R 55 Menerba 55 poloxamer 55 DFMO 55 MGCD# [001] 55 HepG2 cells 55 LHRH antagonist 55 IIa trials 55 Advexin 55 cytotoxic effects 55 Alequel 55 Xcytrin R 55 brivanib 55 LymphoStat B belimumab 55 CD# monoclonal antibody 55 SGLT2 inhibitors 55 HCV replication 55 aP2 55 intestinal absorption 55 anti amnesic 55 FGFR4 55 Adult Stem Cell Therapy 55 rThrombin 55 sulindac 55 DDP# 55 casein kinase 55 suppressor gene 55 tubulin inhibitor 55 Cloretazine 55 tolevamer 55 acetonide FA 55 HDL Mimetic Peptide 55 #D#C# 55 CCR5 mAb 55 Zensana 55 Pafuramidine 55 flavopiridol 55 Cytarabine 55 cardiac repolarization 55 Anti Tumor Activity 55 QLT# 55 Decitabine 55 Romiplostim 55 corneal cells 55 CIMZIA ™ 55 BRAF inhibitors 55 Adenosine 55 JAK inhibitors 55 Angiolix 55 Voraxaze 55 Sulonex 55 HuMax EGFr 55 neuroprotective properties 55 targeted antifolate 55 Proxinium TM 55 Talotrexin 55 ARRY # 55 Valtropin 55 Initiates Phase III 55 NRG1 55 CONBRIZA 55 small molecule tyrosine 55 Telatinib 55 Omacetaxine 55 suppress viral replication 55 ThermoDox R 55 HSP# inhibitor 55 zanolimumab 55 INS# [001] 55 CBLC# 55 Beta catenin pathway 55 generation purine nucleoside 55 rtPA 55 desvenlafaxine 55 cytoprotective 55 selective androgen receptor modulator 55 chemopreventive agent 55 drug GAP #B# 55 aurora kinase inhibitor 55 immunotoxin 55 Dalbavancin 55 antitumor efficacy 55 gets USFDA nod 55 pharmacodynamic PD 55 ischemia induced 55 CG# [003] 55 Interferon alpha 55 Spiegelmer 55 oral methylnaltrexone 55 PXD# 55 eniluracil 55 CINOD 55 Posaconazole 55 Temsirolimus 55 GALNS 55 pexiganan 55 Cinryze ™ 55 delivery polymer matrix 55 motor neuron degeneration 55 topoisomerase II inhibitor 55 Phenoptin 55 NPC 1C 55 Phase IIa Clinical Trial 55 ZEVALIN ® 55 bryostatin 55 telomerase activation 55 squalamine 55 kallikrein 55 oral Janus kinase 55 Alogliptin 55 endothelial nitric oxide 55 mecamylamine 55 Preclinical Data 55 endogenous insulin 55 ImClone Erbitux 55 Oglemilast 55 torezolid 55 human IgG1 monoclonal 55 CIMZIA TM 55 HuLuc# 55 proNGF 55 Tofacitinib 55 dual orexin receptor 55 anti CD3 monoclonal 55 oral bioavailability 55 HIF PH inhibitors 55 JAK1 55 candidate deforolimus 55 Elocalcitol 55 Monoclonal Antibody 55 ONCONASE R 55 cancer immunotherapies 55 plasma renin activity 55 metaglidasen 55 antisense oligonucleotide 55 Entry Inhibitor 55 mesylate 55 TET2 55 mediated inhibition 55 choroidal neovascularization 55 Peptide YY 55 RTP# 55 Collategene 55 anticancer activity 55 BRIM3 55 Present Preclinical Data 55 CCR3 55 Tocosol Paclitaxel 55 AAG geldanamycin analog 55 DU #b 55 histone acetylation 55 ATHX 55 imatinib therapy 55 MEK ERK 55 GeneICE 55 PGC 1α 55 Vilazodone 55 plasminogen activator 55 cMET 55 naturally occurring molecule 55 siRNA therapeutic 55 axonal damage 55 LEP ETU 55 Phase 2a trial 55 Gout Drug 55 non nucleoside inhibitor 55 IGF IR 55 Melphalan 55 successfully commercialize Iluvien 55 Eribulin 55 mTOR inhibitors 55 Cintredekin Besudotox 55 Novel Anticancer 54 immune modulator 54 Golimumab 54 RiVax 54 Ophthotech 54 Chemophase 54 histone deacetylase HDAC inhibitor 54 KIACTA ™ 54 compound INCB# 54 Presents Preclinical 54 Zybrestat 54 Restanza 54 BrachySil TM 54 Clinical Study Shows 54 UPLYSO 54 IMP# 54 Sutent sunitinib 54 SinuNase ™ 54 DOS# 54 pharmacodynamic profile 54 proteasome inhibitors 54 small molecule defensin 54 leukemic stem cells 54 Loxapine 54 LCP Tacro 54 Endothelin 54 Xcellerated T Cells 54 murine monoclonal antibody 54 Icatibant 54 Annamycin 54 Taclonex R 54 hyaluronidase enzyme 54 candidate TNFerade biologic 54 E1 INT TM 54 Arcalyst 54 ANG# 54 ASONEP 54 Treat Parkinson Disease 54 acetylcholinesterase AChE 54 Darinaparsin 54 pharmacodynamic properties 54 acadesine 54 nephrotoxicity 54 PrevOnco 54 ICA # 54 ChronVac C 54 Ecallantide 54 targets Galectin receptors 54 ToGA 54 intestinal mucosal 54 MEK inhibitors 54 thymosin beta 4 54 inhaled AAT 54 verteporfin 54 Apoptone 54 Alvesco R 54 urate oxidase 54 tramiprosate ALZHEMED TM 54 Zarnestra 54 Erbitux cetuximab 54 CB2 selective receptor agonist 54 liposomal formulation 54 neuroblastoma tumors 54 Bazedoxifene 54 Entocort 54 Pradefovir 54 Alfimeprase 54 Receives Orphan Drug Designation 54 trial evaluating PRX# 54 VitiGam TM 54 PANVAC VF 54 VitiGam 54 Neo Kidney Augment 54 Presents Preclinical Data 54 transgenic mouse models 54 Achieves Primary Endpoint 54 RNA antagonist 54 BRAF inhibitor 54 Ercole Biotech 54 neuronal function 54 compound AEOL # 54 deforolimus 54 Excellarate 54 MAXY G# 54 Androgen Receptor 54 elotuzumab 54 Pharmacokinetics PK 54 rasagiline tablets 54 humanised monoclonal antibody 54 RIP1 kinase 54 Presents Positive 54 mGluR4 54 FOXP3 54 OMNARIS HFA 54 alfimeprase 54 eligen 54 Behcet uveitis 54 Eltrombopag 54 Topiramate 54 Fibrillex 54 PDUFA Date 54 triterpenoids 54 OvaRex 54 zileuton CR 54 phase IIa 54 recombinant subunit vaccine